Evidence map›Paper›PMID 41708557›Full record

ArticleCellular and molecular life sciences : CMLS2026

CD177

Li Ji, Yonghao Chen, Liang Gong, Jianing Li, Yangyang Xiong, Yi Zhao, Yunlong Li, Ziying Han, Zihan Yang, Qingwei Jiang and 1 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Li Ji *Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Yonghao Chen *Department of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Liang Gong *Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Jianing LiDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Yangyang XiongDepartment of Gastroenterology, The First Affiliated Hospital, Zhejiang University College of Medicine, Hangzhou, Zhejiang, China.
Yi ZhaoDepartment of Gastrointestinal Surgery, Peking University Cancer Hospital, Beijing, China.
Yunlong LiDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Ziying HanDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Zihan YangDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China.
Qingwei JiangDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China. jiangqingwei@pumch.cn.
Dong WuDepartment of Gastroenterology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, China. 1 Shuaifuyuan Road, Dongcheng District, Beijing, 100730, China. wudong@pumch.cn.ORCID http://orcid.org/0000-0001-9430-9874

Funding

National Key Research and Development Program of China 2024YFA0918504National Natural Science Foundation of China 32170788, 82460135Natural Science Foundation of Beijing Municipality 7232123, 7244390, L248074Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2024-RW320-01the National High Level Hospital Clinical Research Funding 2022-PUMCH-B-023
6 · The paper itself

Abstract

Altered neutrophil infiltration and function are associated with the deterioration of acute pancreatitis (AP) and even AP-associated lung injury. Although CD177 is a marker of neutrophil activation, its role in AP remains largely unknown. To determine whether ablation of Cd177 could deteriorate colonic barrier dysfunction, changes in the gut microbiota, and AP-associated lung injury, Cd177 knock-out (KO), Cd177 conditional knock-out (cKO) in circulating neutrophils and pseudo-germ-free (antibiotic therapy, or ABX-treated) mouse models were used in this study. AP was induced in mice through injection of sodium taurocholate retrogradely into the pancreatic duct, then peripheral blood, pancreas, lung, colon tissues and fecal samples were collected at 24 h after induction, respectively. The mRNA and protein expression of certain genes and gut microbiota of mice were measured. Results indicated that both Cd177 KO and cKO increased serum amylase and lipase levels, exacerbated pathological damage, and impaired the integrity of the colonic mucosal barrier in AP mice, suggesting a protective role of neutrophil-derived CD177 in AP progression. In addition, ABX-treated mice alleviated AP-associated lung injury, demonstrating that gut microbiota dysbiosis may contribute to the deterioration of phenotypes. Moreover, ablation of Cd177 was associated with reduced abundance of gut microbiota species g_Atopostipes, downregulated Nos1ap expression in the lung and Sorbs1 expression in the colon, consequently aggravating the damage of colon and lung of mice with AP. It is concluded that Cd177+ neutrophils may ameliorate AP-associated lung injury through protecting colonic barrier and modulating certain gut microbiota and associated genes in mice.

Indexed as

Acute Lung InjuryColonGastrointestinal MicrobiomeIsoantigensLung InjuryNeutrophilsPancreatitisReceptors, Cell SurfaceAnimalsDisease Models, AnimalGPI-Linked ProteinsIntestinal Barrier FunctionMaleMiceMice, Inbred C57BLMice, KnockoutGPI-Linked ProteinsIsoantigensReceptors, Cell SurfaceAcute pancreatitisCD177Gut-lung axisGut microbiotaLung injuryNeutrophil

Identifiers

PMID41708557
PMCPMC12932795

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.